文献速递毛发、甲与色素性疾病

通过比较转录组分析揭示男性雄激素性脱发:缺氧诱导因子-1与Wnt/β-catenin信号通路

Insights into male androgenetic alopecia using comparative transcriptome profiling: hypoxia-inducible factor-1 and Wnt/β-catenin signalling pathways.
PubMed 文献 · Br J Dermatol · 2022-09-01

研究对10名男性雄激素性脱发(AGA)患者的秃发区(头顶)和非秃发区(枕部)毛囊进行RNA测序,发现506个mRNA、55个microRNA和127个长链非编码RNA差异表达,涉及HIF-1、Wnt/β-catenin等通路;体外实验验证EGLN1、EGLN3、SERPINF1和SFRP2可能作为治疗靶点。

要点

  • AGA头顶与枕部毛囊存在转录组差异,涉及HIF-1和Wnt/β-catenin通路。
  • EGLN1、EGLN3、SERPINF1和SFRP2下调可促进毛乳头细胞增殖和毛囊生长。
  • 这些基因可能作为AGA的潜在治疗靶点。

核心结论

  • 男性AGA毛囊存在关键转录组改变,HIF-1通路相关基因(EGLN1、EGLN3)和Wnt通路抑制剂(SERPINF1、SFRP2)可能在AGA中起重要作用。

研究设计与样本

  • 收集10名男性AGA患者配对的头顶和枕部毛囊进行RNA测序,并对鉴定出的关键基因进行毛囊和细胞实验。

主要发现

  • 转录组分析显示AGA头顶毛囊中506个mRNA、55个microRNA和127个长链非编码RNA差异表达。
  • mRNA和microRNA通路分析涉及缺氧诱导因子(HIF)-1、Wnt/β-catenin和黏着斑通路。
  • 实验验证了HIF-1脯氨酰羟化酶(EGLN1、EGLN3)和Wnt/β-catenin通路抑制剂(SERPINF1、SFRP2)的差异表达。
  • 体外研究表明,降低EGLN1、EGLN3、SERPINF1和SFRP2可刺激毛乳头细胞增殖。
  • 离体毛囊研究表明,下调EGLN1、EGLN3和SERPINF1可促进毛囊生长、推迟毛囊退行期转换并延长生长期。

临床怎么用

  • 作者认为EGLN1、EGLN3、SERPINF1和SFRP2基因可能作为AGA的潜在治疗靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The key pathophysiological changes in androgenetic alopecia (AGA) are limited to hair follicles (HFs) in frontal and vertex regions, sparing the occipital region. OBJECTIVES: To identify biological differences among HF subpopulations. METHODS: Paired vertex and occipital HFs from 10 male donors with AGA were collected for RNA sequencing assay. Furthermore, HF and cell experiments were conducted on the identified key genes to reveal their roles in AGA. RESULTS: Transcriptome profiles revealed that 506 mRNAs, 55 microRNAs and 127 long noncoding RNAs were differentially expressed in the AGA vertex HFs. Pathway analysis of mRNAs and microRNAs revealed involvement of the hypoxia-inducible factor (HIF)-1, Wnt/β-catenin, and focal adhesion pathways. Differential expression of HIF-1 prolyl hydroxylase enzymes (EGLN1, EGLN3) and Wnt/β-catenin pathway inhibitors (SERPINF1, SFRP2) was experimentally validated. In vitro studies revealed that reduction of EGLN1, EGLN3, SERPINF1 and SFRP2 stimulated proliferation of dermal papilla cells. Ex vivo HF studies showed that downregulation of EGLN1, EGLN3 and SERPINF1 promoted HF growth, postponed HF catagen transition, and prolonged the anagen stage, suggesting that these genes may be potentially utilized as therapeutic targets for AGA. CONCLUSIONS: We characterized key transcriptome changes in male AGA HFs, and found that HIF-1 pathway-related genes (EGLN1, EGLN3) and Wnt pathway inhibitors (SERPINF1, SFRP2) may play important roles in AGA. What is already known about this topic? Multiple differentially expressed genes and signalling pathways have been found between hair follicles (HFs) in the balding area (frontal and vertex regions) and nonbalding area (occipital region) of individuals with androgenetic alopecia (AGA). A whole-transcriptome atlas of the vertex and occipital region is lacking. What does this study add? We identified a number of differentially expressed genes and pathways between balding vertex and nonbalding occipital AGA HFs by using whole-transcriptome analyses. We identified pathways not previously reported in AGA, such as the hypoxia-inducible factor (HIF)-1 signalling pathway. We verified that HIF-1 pathway-related genes (EGLN1, EGLN3) and Wnt pathway inhibitors (PEDF, SFRP2) played important roles in dermal papilla cell activity, hair growth and the hair cycle. What is the translational message? The EGLN1, EGLN3, SERPINF1 and SFRP2 genes may be potentially utilized as therapeutic targets for AGA.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Liu Q, Tang Y, Huang Y, et al. Insights into male androgenetic alopecia using comparative transcriptome profiling: hypoxia-inducible factor-1 and Wnt/β-catenin signalling pathways. Br J Dermatol. 2022. PMID: 35862273. doi:10.1111/bjd.21783

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。